Anti-NXP2 antibody-positive dermatomyositis developed after COVID-19 manifesting as type I interferonopathy

Yuri Okada; Rumiko Izumi; Tatsuhiko Hosaka; Satoshi Watanabe; Tomomi Shijo; Naokazu Hatchome; Risa Konishi; Yuki Ichimura; Naoko Okiyama; Naoki Suzuki; Tatsuro Misu; Masashi Aoki

doi:10.1093/rheumatology/keab872

Anti-NXP2 antibody-positive dermatomyositis developed after COVID-19 manifesting as type I interferonopathy

Yuri Okada, Rumiko Izumi, Tatsuhiko Hosaka, Satoshi Watanabe, Tomomi Shijo, Naokazu Hatchome, Risa Konishi, Yuki Ichimura, Naoko Okiyama, Naoki Suzuki, Tatsuro Misu, Masashi Aoki

Research output: Contribution to journal › Letter › peer-review

5 Citations (Scopus)

Original language	English
Pages (from-to)	E90-E92
Journal	Rheumatology (United Kingdom)
Volume	61
Issue number	4
DOIs	https://doi.org/10.1093/rheumatology/keab872
Publication status	Published - 2022 Apr 1

ASJC Scopus subject areas

Rheumatology
Pharmacology (medical)

Access to Document

10.1093/rheumatology/keab872

Cite this

@article{63fbc1eeba2542e296e8ce52e116a5c6,

title = "Anti-NXP2 antibody-positive dermatomyositis developed after COVID-19 manifesting as type I interferonopathy",

author = "Yuri Okada and Rumiko Izumi and Tatsuhiko Hosaka and Satoshi Watanabe and Tomomi Shijo and Naokazu Hatchome and Risa Konishi and Yuki Ichimura and Naoko Okiyama and Naoki Suzuki and Tatsuro Misu and Masashi Aoki",

year = "2022",

month = apr,

day = "1",

doi = "10.1093/rheumatology/keab872",

language = "English",

volume = "61",

pages = "E90--E92",

journal = "Rheumatology and Rehabilitation",

issn = "1462-0324",

publisher = "Oxford University Press",

number = "4",

}

TY - JOUR

T1 - Anti-NXP2 antibody-positive dermatomyositis developed after COVID-19 manifesting as type I interferonopathy

AU - Okada, Yuri

AU - Izumi, Rumiko

AU - Hosaka, Tatsuhiko

AU - Watanabe, Satoshi

AU - Shijo, Tomomi

AU - Hatchome, Naokazu

AU - Konishi, Risa

AU - Ichimura, Yuki

AU - Okiyama, Naoko

AU - Suzuki, Naoki

AU - Misu, Tatsuro

AU - Aoki, Masashi

PY - 2022/4/1

Y1 - 2022/4/1

UR - http://www.scopus.com/inward/record.url?scp=85124945403&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85124945403&partnerID=8YFLogxK

U2 - 10.1093/rheumatology/keab872

DO - 10.1093/rheumatology/keab872

M3 - Letter

C2 - 34850853

AN - SCOPUS:85124945403

SN - 1462-0324

VL - 61

SP - E90-E92

JO - Rheumatology and Rehabilitation

JF - Rheumatology and Rehabilitation

IS - 4

ER -

Anti-NXP2 antibody-positive dermatomyositis developed after COVID-19 manifesting as type I interferonopathy

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this